Methamphetamine exposure antagonizes N-methyl-d-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures

Brain Research

Volumn 1157, Issue 1, 2007, Pages 74-80

  Smith, Katherine J ^a   Self, Rachel L ^a   Butler, Tracy R ^a   Mullins, Michael M ^a   Ghayoumi, Layla ^a   Holley, Robert C ^a   Littleton, John M ^a   Prendergast, Mark A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amphetamine; Excitotoxicity; Glutamate; Hippocampus; Stimulants

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; DEXTROMETHORPHAN; DIZOCILPINE; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROPIDIUM IODIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; LIGAND BINDING; MALE; NERVE CELL CULTURE; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANIMALS, NEWBORN; BINDING, COMPETITIVE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; MALE; METHAMPHETAMINE; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; PYRAMIDAL CELLS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 34250643632     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.056     Document Type: Article

References (34)

1. Anderson K.L., and Itzhak Y. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse. Ann. N.Y. Acad. Sci. 1074 (2006) 225-233
2. Avignone E., Frenguelli B.G., and Irving A.J. Differential responses to NMDA receptor activation in rat hippocampal interneurons and pyramidal cells may underlie enhanced pyramidal cell vulnerability. Eur. J. Neurosci. 22 12 (2005) 3077-3090
3. Castro N.G., de Mello C.F., de Mello F.G., and Aracava Y. Direct inhibition of the N-methyl-d-aspartate receptor channel by dopamine and (+)SKF3893. Br. J. Pharmacol. 126 (1999) 1847-1855
4. Cho A.K., Melega W.P., Kuczenski R., and Segal D.S. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39 (2001) 161-166
5. Chung H., Park M., Hahn E., Choi H., Choi H., and Lim M. Recent trends of drug abuse and drug-associated deaths in Korea. Ann. N. Y. Acad. Sci. 1025 (2004) 458-464
6. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 (2001) 1-22
7. Ernst T., Chang L., Leonido-Yee M., and Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54 (2000) 1344-1349
8. Friedman S.D., Castaneda E., and Hodge G.K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 61 1 (1998) 35-44
9. Gee C.E., Benquet P., Raineteau O., Rietschin L., Kirbach S.W., and Gerber U. NMDA receptors and the differential ischemic vulnerability of hippocampal neurons. Eur. J. Neurosci. 23 10 (2006) 2595-2603
10. Gehrke B.J., Cass W.A., and Bardo M.T. Monoamine-depleting doses of methamphetamine in enriched and isolated rats: consequences for subsequent methamphetamine-induced hyperactivity and reward. Behav. Pharmacol. 17 (2006) 499-508
11. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 11 1 (1969) 1-21
12. Harris B.R., Gibson D.A., Prendergast M.A., Blanchard J.A., Holley R.C., Hart S.R., Scotland R.L., Foster T.C., Pedigo N.W., and Littleton J.M. The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between mGluR5s and NMDARs. Alcohol. Clin. Exp. Res. 27 (2003) 1724-1735
13. Hayter A.J. The maximum familywise error rate of Fisher's least significant difference test. J. Am. Stat. Assoc. 81 (1986) 1000-1004
14. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.D., Heaton R.K., Ellis R.J., and Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry 162 8 (2005) 1461-1472
15. Kaiya H., Takeuchi K., Yoshida H., Kondo T., Sanpei F., Okada Y., and Namba M. Effects of subchronic treatment of methamphetamine haloperidol on the rat brain levels of GABA, glutamate, and aspartate. Folia Psychiatr. Neurol. Jpn. 37 1 (1983) 107-113
16. 3H]kainate binding sites in rat hippocampal long-term slice cultures isolated from external afferents. Anat. Embryol. 203 (2001) 491-500
17. Melega W.P., Williams A.E., Schmitz D.A., DiStefano E.W., and Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J. Pharmacol. Exp. Ther. 274 1 (1995) 90-96
18. Melega W.P., Cho A.K., Harvey D., and Laæan G. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61 (2007) 216-220
19. Moriguchi S., Watanabe S., Kita H., and Nakanishi H. Enhancement of N-methyl-d-aspartate receptor-mediated excitatory postsynaptic potentials in the neostriatum after methamphetamine sensitization. Exp. Brain Res. 144 (2002) 238-246
20. Mulholland P.J., and Prendergast M.A. Transection of intrinsic polysynaptic pathways reduces N-methyl-d-aspartate neurotoxicity in hippocampal slice cultures. Neurosci. Res. 46 (2003) 369-376
21. Office of National Drug Control Policy. Drug policy information clearinghouse fact sheet: methamphetamine. Executive Office of the President (2003) 1-6
22. Ohmori T., Koyama T., Muraki A., and Yamashita I. Competitive and noncompetitive N-methyl-d-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions. J. Neural. Transm. Gen. Sect. 92 2-3 (1993) 97-106
23. Prendergast M.A., Rogers D.T., Mulholland P.J., Self R.L., Littleton J.M., and Nath A. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine-sensitive site on the N-methyl-d-aspartate receptor. Brain Res. 854 (2002) 300-307
24. Prendergast M.A., Harris B.R., Mulholland P.J., Blanchard J.A., Gibson I.I., Holley D.A., and Littleton R.C. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-d-aspartate receptors. Neuroscience 124 (2004) 869-877
25. Rau K.S., Birdsall E., Volz T.J., Riordan J.A., Baucum II A.J., Adair B.J., Bitter R., Gibb J.W., Hanson G.R., and Fleckenstein A.E. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake. J. Pharmacol. Exp. Ther. 318 (2006) 676-682
26. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., and Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methamphetamine in the rat brain. Brain Res. 235 (1982) 93-103
27. Rocher C., and Gardier A.M. Effects of repeated systemic administration of d-fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 363 4 (2001) 422-428
28. Self R.L., Smith K.J., Mulholland P.J., and Prendergast M.A. Ethanol exposure and withdrawal sensitizes the rat hippocampal CA1 pyramidal cell region to beta-amyloid (25-35)-induced cytotoxicity: NMDA receptor involvement. Alcohol., Clin. Exp. Res. 29 11 (2005) 2063-2069
29. Shoblock J.R., Maisonneuve I.M., and Glick S.D. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology 170 (2003) 150-156
30. Stephans S.E., and Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17 (1994) 203-209
31. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., and London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24 26 (2004) 6028-6036
32. Yamamoto B.K., and Bankson M.G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 17 (2005) 87-118
33. Yeh G.C., Chen J.C., Tsai H.C., Wu H.H., Lin C.Y., Hsu P.C., and Peng Y.C. Amphetamine inhibits the N-methyl-d-aspartate receptor-mediated responses by directly interacting the receptor/channel complex. J. Pharmacol. Exp. Ther. 300 3 (2002) 1008-1016
34. Zimmer J., Kristensen B.W., Jakobsen B., and Noraberg J. Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 19 (2000) 7-21